PMC:6194691 / 144094-144524 JSONTXT

{"project":"MyTest","denotations":[{"id":"30340614-14523085-30706459","span":{"begin":100,"end":103},"obj":"14523085"},{"id":"30340614-12427834-30706460","span":{"begin":105,"end":108},"obj":"12427834"},{"id":"30340614-9242912-30706461","span":{"begin":258,"end":261},"obj":"9242912"},{"id":"30340614-25999850-30706462","span":{"begin":392,"end":395},"obj":"25999850"}],"namespaces":[{"prefix":"_base","uri":"https://www.uniprot.org/uniprot/testbase"},{"prefix":"UniProtKB","uri":"https://www.uniprot.org/uniprot/"},{"prefix":"uniprot","uri":"https://www.uniprot.org/uniprotkb/"}],"text":"There is evidence that plaques in the brain can be removed by reducing the ISF concentration of Aβ [428, 442]. However, it is likely that this only occurs if the Aβ concentration can be reduced to levels below those present before aggregate formation began [431]. This has been shown experimentally but it may not be achievable in practice without both inhibition of Aβ production (see e.g. [443]) and enhancement of Aβ clearance."}

{"project":"2_test","denotations":[{"id":"30340614-14523085-30706459","span":{"begin":100,"end":103},"obj":"14523085"},{"id":"30340614-12427834-30706460","span":{"begin":105,"end":108},"obj":"12427834"},{"id":"30340614-9242912-30706461","span":{"begin":258,"end":261},"obj":"9242912"},{"id":"30340614-25999850-30706462","span":{"begin":392,"end":395},"obj":"25999850"}],"text":"There is evidence that plaques in the brain can be removed by reducing the ISF concentration of Aβ [428, 442]. However, it is likely that this only occurs if the Aβ concentration can be reduced to levels below those present before aggregate formation began [431]. This has been shown experimentally but it may not be achievable in practice without both inhibition of Aβ production (see e.g. [443]) and enhancement of Aβ clearance."}